Looking at top Wall Street opinions, UnitedHealth Group Incorporated (NYSE: UNH) has recently made its way into the research list of Citigroup – signaling that their analyst’s rating adjustment is noteworthy. This stock was upgraded to a rating of Buy in the eyes of Citigroup, whereas its previous rating was Neutral in the eyes of Citigroup, as reported on Friday, May 10th, 2019. Another heavy-hitting research note was published by UBS on Tuesday April 23rd, 2019, with this firm Initiated UNH to an updated rating of Neutral. In the past six months and three months of trading, shares of UnitedHealth Group Incorporated (UNH) have moved by -5.42% and 5.41%, respectively.
Brokerage Updates Related to UnitedHealth Group Incorporated (UNH) Stock
This publicly-traded organization generated gains of 0.38% over the last 5 sessions. Right now, this stock is the subject of 25 analysts’ evaluations, who – on average – have given this company’s shares a Strong Buy rating. Not a Single analyst have given underperform rating or sell rating, and 11 have given a rating of Buy or better. Based on the 25 stock market experts following this company, the average 12-month price target is $296.26. Moreover, individual price targets range between $264.00-$330.00. With its recent move to $295.00, we can see that these firms project this stock will loss by -4.28% in one year.
Updates from UnitedHealth Group Incorporated (UNH) SEC Form 4
This particular company’s shares have garnered a lot of attention in recent days, as insiders are unloading their holdings while having generated a 0.40% rise since the beginning of the calendar year. A Director at UnitedHealth Group Incorporated (UNH) sold off some of its shares in a transaction that was finalized on Aug 08. Similarly, BALLARD WILLIAM C JR sold 12,000 shares of the organization’s stock at $255.31 apiece and racked up $3,063,660 in earnings from the sale. Now, BALLARD WILLIAM C JR holds 61,309 shares of the company following the exchange. A Director of the organization named BURKE RICHARD T, was engaged in a transaction that occurred on Jun 11 that managed to be worth $2,480,000 from the sale of 10,000 common shares at a price of $248.00 per individual share.
UnitedHealth Group Incorporated (NYSE:UNH) Results in the Pipeline
The next scheduled release of financial results for UnitedHealth Group Incorporated will be for the Jun-19 quarter. As it stands right now, market analysts are anticipating the per-share earnings for the three-month period will be $3.45. In the same vein, they expect sales for the quarter to amount to $60,550.50 million.
Now let’s turn to earnings surprise history: in the most recent quarter, the company reported about $60,595.00 million in revenue alongside EPS at $3.60. On average, the analyst projection was calling for $60,308.00 million with $3.73 per share in earnings, respectively. In the preceding quarter, this company’s revenue reached $58,417.00 million, with earnings per share ending up at $3.28.
Henry Schein, Inc. (NASDAQ:HSIC) experienced a drop of -0.54% from the closing price in the previous trading day. That drove the price to $62.28 per share, as observed on January 1st, 1970, at a time when the total trading volume reached 1,736,873 shares of stock – compared to the typical average of 1.36M shares per day (as recorded over the past three months). The consensus estimate for these shares has been shifted to $66.00.
Pricing Indications for Henry Schein, Inc. (HSIC)
This organization has had a price-to-earnings ratio of 19.78 in the last year. Meanwhile, it gained 68.31 from its observable 50-day simple moving average. Right at this moment, the per-share value is -3.25% lower than the mean per-share price over the last 200 days in the market.
Henry Schein, Inc. (NASDAQ:HSIC) In-Depth Brokerage Insights
We can see that a number of brokerage firms are putting their focus onto this stock. Out of this group, 2 have a sell rating, 1 have a Buy rating, 4 have an outperform rating, while 10 provided a Hold rating for these shares – thanks to data from Thomson Reuters I/B/E/S. Additionally, 1 have recommended that these shares are an Underperforming investment. The current consensus recommendation is at 2.80, based on information from Thomson Reuters.
HSIC Stock Value Potential
In trading activity as of late, this stock’s value was 64.38 up from its 200 day moving average, while also -8.90% down when compared against its 50-day simple moving average. Over the course of the past year of trading, the share price stuck in the range of $55.00-$75.00. The market value for the entire organization reached 9.17B. In the last trading session, the price ended the day at $62.62. The institutional holdings related to this organization account for 1.00%, and the Beta factor is now 0.85. This company’s RSI (Relative Strength Index) managed to hit 28.25.
Henry Schein, Inc. (NASDAQ:HSIC) Analyst Points of Focus
Henry Schein, Inc. (HSIC) has found itself inside of William Blair’s research list, so their analyst rating adjustment is worth taking note of. This stock was downgraded to Mkt Perform, compared to its previous rating of Outperform by William Blair, as garnered from a news report on Wednesday August 7th, 2019. An additional helpful research note was sent out by Wolfe Research’s on Thursday May 30th, 2019. The brokerage decided to initiated HSIC to Underperform.